Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 2/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 9/20 | 0.35 |
| ▸ | BPTF | Q12830 | 1/20 | 0.35 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CDK7 | P50613 | 1/20 | 0.33 |
| ▸ | CCNH | P51946 | 1/20 | 0.33 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38662138 | 0.83 | NOS1 (0.39) | JAK3KAT2BBPTFEGLN2MEN1 | |
| SCHEMBL38664072 | 0.77 | USP30 (0.46) | JAK3MEN1KMT2A | |
| SCHEMBL38661215 | 0.64 | GPR119 (0.42) | MEN1KMT2A | |
| SCHEMBL38661657 | 0.62 | FPR2 (0.47) | JAK3MEN1KMT2A | |
| SCHEMBL17459864 | 0.62 | XDH (0.43) | AR | |
| SCHEMBL496338 | 0.61 | MAPT (0.50) | MEN1KMT2AL3MBTL1CSF1RAR | |
| SCHEMBL25370072 | 0.61 | EGFR (0.35) | MEN1KMT2AAR | |
| SCHEMBL38661074 | 0.61 | USP30 (0.48) | — | |
| SCHEMBL495856 | 0.61 | MEN1 (0.48) | MEN1KMT2AL3MBTL1NOS1NOS2 | |
| SCHEMBL6987540 | 0.61 | MAOA (0.40) | MEN1KMT2ACSF1RNOS2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098672-A1 | BIAZACYCLOALKANE MENIN-MLL PROTEIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 赛诺哈勃药业（成都）有限公司 | 2026-05-15 | — | — | WO | disclosed |